Nephros, Inc. (NEPH)

Nephros Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-1.44	-1.58	-7.38	-4.11	-4.77	-3.42
Depreciation & Amortization	0.2	0.21	0.35	0.25	0.21	0.2
Share-Based Compensation	0.72	1.05	0.98	1.26	0.78	1.33
Other Operating Activities	0.4	1.14	2.82	1.18	-3.12	-0.39
Operating Cash Flow	-0.12	0.83	-3.23	-1.42	-6.9	-2.28
Capital Expenditures	-0.08	-0.08	-0.14	-0.04	-0.24	-0.01
Acquisitions	0	0	0	-0.05	0	-0.14
Investing Cash Flow	-0.08	-0.08	-0.14	-0.09	-0.24	-0.15
Share Issuance / Repurchase	0	0	0.16	0.5	11.62	2.74
Debt Issued / Paid	-0.01	-0.08	-0.29	-0.26	-0.32	-0.63
Other Financing Activities	-	-	0.16	-	-0.09	-0.09
Financing Cash Flow	-0.01	-0.08	0.03	0.24	11.22	2.02
Exchange Rate Effect	0	0	-0	-0.01	0.01	-0.01
Net Cash Flow	-0.2	0.67	-3.34	-1.28	4.08	-0.42
Free Cash Flow	-0.2	0.75	-3.37	-1.45	-7.14	-2.29
Free Cash Flow Margin	-1.39%	5.28%	-33.79%	-14.22%	-83.42%	-22.16%
Free Cash Flow Per Share	-0.02	0.07	-0.33	-0.14	-0.79	-0.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).